Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-05-06Clinical Trial Update: StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients [NA]
A clinical trial evaluating StrataXRT for prevention and treatment of radiation dermatitis in breast cancer or head and neck cancer patients…
-
CLINICAL_TRIALS withdrawal · 2024-05-02Clinical Trial Update: Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations [Phase 1]
A Phase 1 trial evaluating the addition of magrolimab to olaparib for BRCA-mutated metastatic breast cancer or castration-resistant prostate…
-
CLINICAL_TRIALS withdrawal · 2024-04-30Clinical Trial Update: To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer [Phase 2]
Phase 2 trial of oral reparixin for fatigue and locally advanced or metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-02-26Clinical Trial Update: A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer [Phase 3]
A Phase 3 neoadjuvant trial comparing TCbHP vs ECHP-THP in HER2-positive breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-07-06Clinical Trial Update: Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer [Phase 4]
Clinical trial update indicates withdrawal of a Phase 4 study evaluating metformin to reduce disparities in newly diagnosed breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. [Phase 3]
Clinical trial comparing ZOLADEX 10.8 mg vs 3.6 mg in Chinese pre-menopausal ER+ HER2- early breast cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-25Clinical Trial Update: Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy [Phase 3]
A Phase 3 trial evaluating individualized locoregional treatment after primary systemic therapy for node-positive breast cancer has been wit…
-
CLINICAL_TRIALS withdrawal · 2020-10-30Clinical Trial Update: Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) [Phase 1, Phase 2]
Phase 1/2 trial evaluating 177Lu-OPS201 with 68Ga-OPS202 imaging in somatostatin receptor 2–expressing cancers; study terminated with posted…
-
CLINICAL_TRIALS withdrawal · 2020-09-16Clinical Trial Update: Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies [Phase 4]
Phase 4 trial comparing serratus anterior muscle plane block to thoracic paravertebral block for unilateral mastectomies has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-11-26Clinical Trial Update: A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing pertuzumab plus trastuzumab with vinorelbine vs placebo plus trastuzumab with docetaxel in previously untreated HE…
-
CLINICAL_TRIALS withdrawal · 2019-09-06Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer [Phase 4]
A Phase 4 trial of abemaciclib in HR+, HER2- advanced/metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: Metastatic Breast Cancer Treatment Planning [NA]
A clinical trial sponsored by Carevive Systems (NCT03127332) studying metastatic breast cancer treatment planning has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-24Clinical Trial Update: Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy [NA]
A clinical trial evaluating prophylactic treatment to prevent sleep disturbance and fatigue in breast cancer patients undergoing chemotherap…
-
CLINICAL_TRIALS withdrawal · 2018-12-27Clinical Trial Update: Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer [Phase 4]
A Phase 4 clinical trial evaluating endocrine therapy for HER2-negative, low-risk invasive breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-10-22Clinical Trial Update: Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer [Phase 3]
Phase 3 trial investigating enzalutamide with paclitaxel vs placebo with paclitaxel in advanced triple-negative breast cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating Glembatumumab Vedotin in combination with nivolumab and ipilimumab for advanced, unresectable solid tu…
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery [Phase 4]
A Phase 4 trial evaluating outcomes of FlexHD versus Alloderm in breast reconstruction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer [NA]
A clinical trial evaluating KeraStat Skin Therapy for radiation dermatitis in patients with newly diagnosed stage 0-IIIA breast cancer has b…
-
CLINICAL_TRIALS withdrawal · 2018-06-06Clinical Trial Update: Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer
A clinical trial evaluating how body weight affects the pharmacokinetics of doxorubicin and cyclophosphamide in breast cancer has been withd…
-
CLINICAL_TRIALS withdrawal · 2018-05-31Clinical Trial Update: Optimal Injection Site for Serratus Anterior Plane Block in Reconstructive Breast Surgery [Phase 3]
Phase 3 trial evaluating the optimal injection site for serratus anterior plane block in reconstructive breast surgery was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-30Clinical Trial Update: Eniluracil Hand Foot Syndrome [Phase 1]
The Phase 1 trial of eniluracil for breast cancer and colon cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2018-05-22Clinical Trial Update: Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating carboplatin with or without ZD4054 in metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-16Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of chemotherapy and peripheral stem cell transplantation followed by trastuzumab for metastatic breast cancer has been wit…
-
CLINICAL_TRIALS withdrawal · 2018-04-11Clinical Trial Update: A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment
The clinical trial evaluating a novel infrared breast imaging system for breast cancer risk assessment has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-10Clinical Trial Update: Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia [NA]
The clinical trial comparing serratus anterior plane block versus paravertebral block for postmastectomy analgesia in breast cancer patients…